Supporting Weight Management during COVID-19 (SWiM-C): twelve-month follow-up of a randomised controlled trial of a web-based, ACT-based, guided self-help intervention.


Journal

International journal of obesity (2005)
ISSN: 1476-5497
Titre abrégé: Int J Obes (Lond)
Pays: England
ID NLM: 101256108

Informations de publication

Date de publication:
01 2023
Historique:
received: 22 07 2022
accepted: 24 10 2022
revised: 20 10 2022
pubmed: 13 11 2022
medline: 14 1 2023
entrez: 12 11 2022
Statut: ppublish

Résumé

We developed a guided self-help intervention (Supporting Weight Management during COVID-19, "SWiM-C") to support adults with overweight or obesity in their weight management during the COVID-19 pandemic. This parallel, two-group trial (ISRCTN12107048) evaluated the effect of SWiM-C on weight and determinants of weight management over twelve months. Participants (≥18 years, body-mass-index ≥25 kg/m SWiM-C is based on acceptance and commitment therapy (ACT). Participants had access to an online web platform with 12 weekly modules and email and telephone contact with a trained, non-specialist coach. Standard advice was a leaflet on managing weight and mood during the COVID-19 pandemic. 388 participants were randomised (SWiM-C: n = 192, standard advice: n = 196). The baseline-adjusted difference in weight change between SWiM-C (n = 119) and standard advice (n = 147) was -0.81 kg (95% CI: -2.24 to 0.61 kg). SWiM-C participants reported a reduction in experiential avoidance (-2.45 [scale:10-70], 95% CI: -4.75 to -0.15), uncontrolled eating (-3.36 [scale: 0-100], 95% CI: -5.66 to -1.06), and emotional eating (-4.14 [scale:0-100], 95% CI: -7.25 to -1.02) and an increase in physical activity (8.96 [MET-min/week], 95% CI: 0.29 to 17.62) compared to standard advice participants. We found no evidence of an effect on remaining outcomes. No adverse events/side effects were reported. Whilst we were unable to conclude that the intervention had an effect on weight, SWiM-C improved eating behaviours, experiential avoidance and physical activity. Further refinement of the intervention is necessary to ensure meaningful effects on weight prior to implementation in practice. ISRCTN 12107048.

Identifiants

pubmed: 36369513
doi: 10.1038/s41366-022-01232-x
pii: 10.1038/s41366-022-01232-x
pmc: PMC9651901
doi:

Banques de données

ISRCTN
['ISRCTN12107048']

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

51-59

Subventions

Organisme : Medical Research Council
ID : MC_UU_00006/6
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/4
Pays : United Kingdom
Organisme : Department of Health
ID : RP-PG-0216-20010
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022. The Author(s).

Références

JMIR Res Protoc. 2016 Oct 14;5(4):e180
pubmed: 27742602
Nutrients. 2020 Nov 10;12(11):
pubmed: 33182816
Curr Dev Nutr. 2022 Apr 08;6(4):nzac011
pubmed: 35415391
Transl Behav Med. 2021 Aug 13;11(8):1527-1536
pubmed: 33787926
BMJ. 2013 Jan 21;346:e8668
pubmed: 23338004
Am J Clin Nutr. 2005 Mar;81(3):564-9
pubmed: 15755823
Lancet. 2015 Feb 14;385(9968):640-648
pubmed: 25468152
Am J Public Health. 2015 Mar;105(3):e43-57
pubmed: 25602873
Am J Clin Nutr. 2018 Mar 1;107(3):420-426
pubmed: 29566188
Behav Modif. 2011 May;35(3):252-64
pubmed: 21362746
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Obes Rev. 2020 Jul;21(7):e13013
pubmed: 32181957
Qual Life Res. 2012 Feb;21(1):167-76
pubmed: 21598064
Int J Environ Res Public Health. 2022 Apr 20;19(9):
pubmed: 35564376
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Circ Res. 2016 May 27;118(11):1703-5
pubmed: 27230636
J Affect Disord. 2020 Nov 1;276:45-52
pubmed: 32697715
Appetite. 2021 Mar 1;158:105017
pubmed: 33161044
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Public Health Nutr. 2012 Jun;15(6):989-99
pubmed: 22152926
Obesity (Silver Spring). 2015 Mar;23(3):558-64
pubmed: 25611944
JMIR Diabetes. 2020 Jan 20;5(1):e15189
pubmed: 31958064
Obes Res. 2003 Oct;11 Suppl:44S-59S
pubmed: 14569037
Metabolism. 2021 Apr;117:154703
pubmed: 33421506
Lancet. 2017 Jun 3;389(10085):2214-2225
pubmed: 28478041
JMIR Form Res. 2022 Jan 7;6(1):e31801
pubmed: 34994698
Public Health Nutr. 2017 Jun;20(9):1681-1691
pubmed: 28414018
Obes Surg. 2017 Mar;27(3):586-598
pubmed: 27586525
BMJ Open. 2022 Apr 19;12(4):e058103
pubmed: 35440459
J Obes. 2017;2017:2085136
pubmed: 28744374
J Med Internet Res. 2014 Mar 28;16(3):e95
pubmed: 24681761
Eat Weight Disord. 2017 Mar;22(1):97-104
pubmed: 27460010
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
PLoS One. 2021 Jan 6;16(1):e0244419
pubmed: 33406085
Obes Facts. 2022;15(4):550-559
pubmed: 35417910

Auteurs

Julia Mueller (J)

MRC Epidemiology Unit, University of Cambridge, Cambridge, UK. Julia.Mueller@mrc-epid.cam.ac.uk.

Rebecca Richards (R)

MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.

Rebecca A Jones (RA)

MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.

Fiona Whittle (F)

MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.

Jennifer Woolston (J)

MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.

Marie Stubbings (M)

MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.

Stephen J Sharp (SJ)

MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.

Simon J Griffin (SJ)

MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.
Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Jennifer Bostock (J)

Patient and Public Involvement representative, Cambridge, UK.

Carly A Hughes (CA)

Fakenham Medical Practice, Fakenham, UK.
Medical School, University of East Anglia, Norwich, UK.

Andrew J Hill (AJ)

Division of Psychological and Social Medicine, School of Medicine, University of Leeds, Leeds, UK.

Clare E Boothby (CE)

MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.

Amy L Ahern (AL)

MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH